Literature DB >> 21622880

Mannan oligosaccharide modulates gene expression profile in pigs experimentally infected with porcine reproductive and respiratory syndrome virus.

T M Che1, R W Johnson, K W Kelley, W G Van Alstine, K A Dawson, C A Moran, J E Pettigrew.   

Abstract

This study characterized gene expression in peripheral blood mononuclear cells (PBMC) and bronchoalveolar lavage fluid (BALF) cells from control- or mannan oligosaccharide (MOS)-fed pigs with or without porcine reproductive and respiratory syndrome virus (PRRSV) at d 7 postinfection (PI). Weaned pigs (3 wk old) fed 0 or 0.2% MOS (Bio-Mos) diets were intranasally inoculated with PRRSV or a sterile medium at 5 wk of age. Total RNA (3 pigs/treatment) was extracted from cells. Double-stranded cDNA was amplified, labeled, and further hybridized to the Affymetrix GeneChip Porcine Genome Array consisting of 23,937 probe sets representing 20,201 genes. Microarray data were analyzed in R using packages from the Bioconductor project. Differential gene expression was tested by fitting a mixed linear model equivalent to a 2 × 2 factorial ANOVA using the limma package. Dietary MOS and PRRSV changed the expression of thousands of probe sets in PBMC and BALF cells (P < 0.05). The MOS × PRRSV interaction altered the expression of more nonimmune probe sets in PBMC (977 up, 1,128 down) than in BALF cells (117 up, 78 down). The MOS × PRRSV interaction (P < 0.05) for immune probe sets in PBMC affected genes encoding key inflammatory mediators. In uninfected pigs, gene expression of IL-1α, IL-6, myeloid differentiation factor 88, Toll-like receptor (TLR) 4, major histocompatibility complex (MHC) II, and dead box polypeptide 58 increased in PBMC of MOS-fed pigs (P < 0.05). This suggests that MOS enhances disease resistance in pigs and supports the fact that MOS induced a rapid increase in leukocytes at d 3 and 7 PI. Within infected pigs, however, MOS reduced the expression of IL-1β, IL-6, IL-8, macrophage inflammatory protein (MIP)-1α, MIP-1β, monocyte chemotactic protein (MCP)-1, and TLR4 genes in PBMC (P < 0.05). This finding may explain why fever was ameliorated in infected pigs fed MOS by d 7 PI. The expression of IL-1β, IL-6, MIP-1β, MCP-1, and TLR4 genes was confirmed by quantitative real-time reverse-transcription PCR. In BALF cells of infected pigs, MOS reduced the gene expression of TLR4, MHCII, and molecules associated with the complement system, but increased the gene expression of MHCI. In short, MOS regulated the expression of nonimmune and immune genes in pig leukocytes, perhaps providing benefits by enhancing the immune responses of the pigs to an infection, while preventing overstimulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622880     DOI: 10.2527/jas.2010-3366

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  14 in total

1.  Mannan oligosaccharide supplementation in diets of sow and (or) their offspring improved immunity and regulated intestinal bacteria in piglet1.

Authors:  Xudong Duan; Gang Tian; Daiwen Chen; Linhui Huang; Dan Zhang; Ping Zheng; Xiangbing Mao; Jie Yu; Jun He; Zhiqing Huang; Bing Yu
Journal:  J Anim Sci       Date:  2019-11-04       Impact factor: 3.159

2.  Dietary plant extracts modulate gene expression profiles in alveolar macrophages of pigs experimentally infected with porcine reproductive and respiratory syndrome virus.

Authors:  Kwangwook Kim; Peng Ji; Minho Song; Tung M Che; David Bravo; James E Pettigrew; Yanhong Liu
Journal:  J Anim Sci Biotechnol       Date:  2020-07-14

3.  Phylogenetic and functional alterations in bacterial community compositions in broiler ceca as a result of mannan oligosaccharide supplementation.

Authors:  A Corrigan; Marcel de Leeuw; Stéphanie Penaud-Frézet; Diliana Dimova; R A Murphy
Journal:  Appl Environ Microbiol       Date:  2015-03-13       Impact factor: 4.792

Review 4.  Mannan Oligosaccharides in Nursery Pig Nutrition and Their Potential Mode of Action.

Authors:  Veronika Halas; Imre Nochta
Journal:  Animals (Basel)       Date:  2012-05-23       Impact factor: 2.752

5.  Genome-wide analysis of antiviral signature genes in porcine macrophages at different activation statuses.

Authors:  Yongming Sang; Wyatt Brichalli; Raymond R R Rowland; Frank Blecha
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Dietary Mannan Oligosaccharides Modulate Gut Microbiota, Increase Fecal Bile Acid Excretion, and Decrease Plasma Cholesterol and Atherosclerosis Development.

Authors:  Lisa R Hoving; Saeed Katiraei; Marieke Heijink; Amanda Pronk; Lianne van der Wee-Pals; Trea Streefland; Martin Giera; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  Mol Nutr Food Res       Date:  2018-05       Impact factor: 5.914

7.  Production and purification of mannan oligosaccharide with epithelial tight junction enhancing activity.

Authors:  Chatchai Nopvichai; Thanapon Charoenwongpaiboon; Navaporn Luengluepunya; Kazuo Ito; Chatchai Muanprasat; Rath Pichyangkura
Journal:  PeerJ       Date:  2019-07-02       Impact factor: 2.984

8.  Evaluation of suitable reference genes for gene expression studies in porcine PBMCs in response to LPS and LTA.

Authors:  Mehmet Ulas Cinar; Mohammad Ariful Islam; Maren Pröll; Hakan Kocamis; Ernst Tholen; Dawit Tesfaye; Christian Looft; Karl Schellander; Muhammad Jasim Uddin
Journal:  BMC Res Notes       Date:  2013-02-08

9.  Dietary yeast-derived mannan oligosaccharides have immune-modulatory properties but do not improve high fat diet-induced obesity and glucose intolerance.

Authors:  Lisa R Hoving; Hendrik J P van der Zande; Amanda Pronk; Bruno Guigas; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

10.  Increasing the ratio of SID lysine to metabolizable energy improves pig performance during a viral challenge.

Authors:  Jessica E Jasper; Omarh F Mendoza; Caleb M Shull; Wesley P Schweer; Kent J Schwartz; Nicholas K Gabler
Journal:  J Anim Sci       Date:  2020-04-01       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.